Jazz Pharmaceuticals
Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to developing and commercializing innovative medicines in oncology and neuroscience. Founded in 2003 in California and now headquartered in Dublin, Ireland, the company focuses on addressing serious diseases that often have limited treatment options. Jazz's portfolio includes therapies for sleep disorders, epilepsy, and cancer. Key products include Xyrem for narcolepsy, Xywav for sleep disorders, Epidiolex and Sativex for neurological conditions, Vyxeos for certain cancers, and Defitelio for rare diseases. The company has expanded its oncology offerings through strategic acquisitions and partnerships, enhancing its pipeline to include treatments for aggressive cancers. With operations in the US and Europe, Jazz Pharmaceuticals emphasizes a patient-first approach and a commitment to innovation. Their research and development efforts aim to deliver life-changing medicines to patients facing serious and rare diseases.
Work at Jazz Pharmaceuticals in HR or recruiting? Claim this page
Headcount trend
Jazz Pharmaceuticals went from 1,558 employees in Jul 2023 to 1,708 in Jun 2025. Jan to Jun 2025: 96 people joined, 51 left.
Headcount data through Jun 2025
Org structure
Headcount by department
Executive compensation
Hiring now
See all jobsSalaries at Jazz Pharmaceuticals
All salaries15 salary profiles in the US
Most reported roles
H-1B sponsorship
The department split adds up all the years listed above. FY2026 alone: 9 filings.
Peer reviews
Worked with someone at Jazz Pharmaceuticals?
Anonymous peer reviews on OffTheRecord
Similar companies
Jazz Pharmaceuticals FAQ
How many employees does Jazz Pharmaceuticals have?
Jazz Pharmaceuticals has about 1,708 employees, up 1.2% over the 3 months to Jun 2025.
Does Jazz Pharmaceuticals sponsor H1B visas?
Yes. Jazz Pharmaceuticals filed 9 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.
What is Jazz Pharmaceuticals's revenue per employee?
Jazz Pharmaceuticals makes about $2.38M in revenue per employee, based on $4.06B annual revenue and 1,708 employees.
How much does Jazz Pharmaceuticals pay?
6figr has 15 salary profiles for Jazz Pharmaceuticals in the US, with pay broken down by role, level, gender and ethnicity on the Jazz Pharmaceuticals salaries page. See Jazz Pharmaceuticals salaries
Is Jazz Pharmaceuticals a public company?
Yes. Jazz Pharmaceuticals is publicly traded under the ticker JAZZ on NASDAQ.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.
